Elanco Launches $25M Ventures Fund for Animal Health
INDIANAPOLIS, Ind., June 18, 2026 Elanco Animal Health Incorporated has announced plans to establish Elanco Ventures, a dedicated corporate...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
INDIANAPOLIS, Ind., June 18, 2026 Elanco Animal Health Incorporated has announced plans to establish Elanco Ventures, a dedicated corporate...
SINGAPORE and SEOUL, South Korea, June 17, 2026 D&D Pharmatech and HistoIndex have announced encouraging new findings from an...
